Baseline factors linked to SLE flares during pregnancy included thrombocytopenia and a history of LN, while antimalarial therapy demonstrated protective effects.
Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback